生物药物对严重不受控制的喘的长期,现实世界的有效性:PROSPECT研究
Kazuhisa Asai1, Takashi Iwanaga2, Mai Takahashi3
1Department of Respiratory Medicine, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahi machi, Abeno-ku, Osaka 545-8585, Japan.
Respiratory investigation
|April 5, 2025
概括
在现实实践中,在24个月内,发起生物药物 (BIO) 显著改善了严重不受控制的喘患者的肺功能和喘控制.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重不受控制的喘缺乏生物制剂 (BIO) 的长期真实有效性数据.
- 有生物制剂可供使用,但它们的持续影响需要进一步调查.
- 这项研究解决了对符合条件的患者生物疗效的长期数据的需求.
研究的目的:
- 评估在严重不受控制的喘中启动生物制剂 (BIO) 的长期有效性.
- 评估24个月的肺功能变化和喘控制.
- 为了比较开始BIO治疗的患者和不开始BIO治疗的患者之间的结果.
主要方法:
- 日本的一项多中心观察队列研究 (PROSPECT).
- 根据在12周内开始治疗的情况,患者被分为BIO和非BIO组.
- 生物药物包括奥马利祖马布,梅波利祖马布,本拉利祖马布和杜比卢马布,由医生自行决定.
主要成果:
- 与非BIO组 (0.04L) 相比,BIO组在24个月内显示出1秒内强制呼气体积 (FEV1) 的显著增加 (0.17L).
- 在BIO组中,在6,12和18个月后观察到FEV1的显著改善.
- 生物组经历了恶化的减少,改善了喘控制问卷得分,降低了口服皮质类固醇剂量,以及更高的戒断率.
结论:
- 启动生物药物 (BIO) 与肺功能的长期显著改善有关.
- 生物药物有效地提高了严重失控喘患者的喘控制.
- 现实世界的数据支持生物药物对严重喘管理的长期益处.
相关概念视频
Antiasthma Drugs: β2-Adrenoceptor Agonists
167
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
167
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
160
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
160
Antiasthma Drugs: Leukotriene Modifiers
180
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
180
COPD: Management Using Bronchodilators and Corticosteroids
148
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
148
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
186
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
186
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106


